###begin article-title 0
Immunodominant Tuberculosis CD8 Antigens Preferentially Restricted by HLA-B
###end article-title 0
###begin p 1
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 115 89 115 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 123 133 123 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 147 169 147 169 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Listeria monocytogenes</named-content>
###xml 675 682 671 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 701 702 697 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 747 748 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1326 1333 1322 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1347 1348 1343 1344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1535 1536 1531 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 115 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 117 120 <span type="species:ncbi:1773">Mtb</span>
###xml 147 169 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 325 328 <span type="species:ncbi:1773">Mtb</span>
###xml 491 494 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 565 568 <span type="species:ncbi:1773">Mtb</span>
###xml 768 775 <span type="species:ncbi:9606">persons</span>
###xml 874 877 <span type="species:ncbi:1773">Mtb</span>
###xml 1519 1522 <span type="species:ncbi:1773">Mtb</span>
###xml 1844 1850 <span type="species:ncbi:9606">humans</span>
CD8+ T cells are essential for host defense to intracellular bacterial pathogens such as Mycobacterium tuberculosis (Mtb), Salmonella species, and Listeria monocytogenes, yet the repertoire and dominance pattern of human CD8 antigens for these pathogens remains poorly characterized. Tuberculosis (TB), the disease caused by Mtb infection, remains one of the leading causes of infectious morbidity and mortality worldwide and is the most frequent opportunistic infection in individuals with HIV/AIDS. Therefore, we undertook this study to define immunodominant CD8 Mtb antigens. First, using IFN-gamma ELISPOT and synthetic peptide arrays as a source of antigen, we measured ex vivo frequencies of CD8+ T cells recognizing known immunodominant CD4+ T cell antigens in persons with latent tuberculosis infection. In addition, limiting dilution was used to generate panels of Mtb-specific T cell clones. Using the peptide arrays, we identified the antigenic specificity of the majority of T cell clones, defining several new epitopes. In all cases, peptide representing the minimal epitope bound to the major histocompatibility complex (MHC)-restricting allele with high affinity, and in all but one case the restricting allele was an HLA-B allele. Furthermore, individuals from whom the T cell clone was isolated harbored high ex vivo frequency CD8+ T cell responses specific for the epitope, and in individuals tested, the epitope represented the single immunodominant response within the CD8 antigen. We conclude that Mtb-specific CD8+ T cells are found in high frequency in infected individuals and are restricted predominantly by HLA-B alleles, and that synthetic peptide arrays can be used to define epitope specificities without prior bias as to MHC binding affinity. These findings provide an improved understanding of immunodominance in humans and may contribute to a development of an effective TB vaccine and improved immunodiagnostics.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 115 89 115 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 123 133 123 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 147 169 147 169 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Listeria monocytogenes</named-content>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 578 579 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 642 643 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 770 771 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 942 943 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 115 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 117 120 <span type="species:ncbi:1773">Mtb</span>
###xml 147 169 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 303 306 <span type="species:ncbi:1773">Mtb</span>
###xml 444 447 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 523 526 <span type="species:ncbi:1773">Mtb</span>
###xml 600 603 <span type="species:ncbi:1773">Mtb</span>
###xml 663 670 <span type="species:ncbi:9606">persons</span>
###xml 685 688 <span type="species:ncbi:1773">Mtb</span>
###xml 721 724 <span type="species:ncbi:1773">Mtb</span>
###xml 926 929 <span type="species:ncbi:1773">Mtb</span>
###xml 1115 1120 <span type="species:ncbi:9606">human</span>
CD8+ T cells are essential for host defense to intracellular bacterial pathogens such as Mycobacterium tuberculosis (Mtb), Salmonella species, and Listeria monocytogenes, yet little is known about the antigens recognized by human CD8+ T cells in response to tuberculosis (TB). TB, the disease caused by Mtb infection, remains one of the leading causes of illness and death worldwide and is a frequent complicating infection in individuals with HIV/AIDS. Therefore, we undertook this study to define commonly recognized CD8 Mtb antigens. First, we measured the frequencies of CD8+ T cells recognizing Mtb antigens known to be recognized by CD4+ T cell antigens in persons infected with Mtb. In addition, we identified the Mtb antigen and epitope recognized by several CD8+ T cell clones isolated from infected individuals. The epitope was presented to the T cell clones by an HLA-B allele in all but one case. We conclude that Mtb-specific CD8+ T cells are found in high frequency in infected individuals and are restricted predominantly by HLA-B alleles. These findings provide an improved understanding of how the human immune system recognizes intracellular pathogens and may contribute to the development of an effective TB vaccine and improved immunodiagnostics.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 15 41 15 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b001">1</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b002">2</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b003">3</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b004">4</xref>
###xml 403 404 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 447 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 597 619 597 619 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Listeria monocytogenes</named-content>
###xml 624 634 624 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b005">5</xref>
###xml 757 758 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 933 934 933 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b006">6</xref>
###xml 935 936 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b008">8</xref>
###xml 1079 1080 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b009">9</xref>
###xml 1129 1131 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b010">10</xref>
###xml 1235 1237 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b011">11</xref>
###xml 1304 1306 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b011">11</xref>
###xml 1307 1309 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b013">13</xref>
###xml 1357 1358 1354 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1426 1428 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b014">14</xref>
###xml 1429 1431 1426 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b015">15</xref>
###xml 1461 1462 1458 1459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1535 1536 1532 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1587 1589 1584 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b016">16</xref>
###xml 1590 1592 1587 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b022">22</xref>
###xml 1645 1647 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b018">18</xref>
###xml 1648 1650 1645 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b023">23</xref>
###xml 1665 1667 1662 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b024">24</xref>
###xml 1668 1670 1665 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b026">26</xref>
###xml 1749 1750 1746 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 41 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 43 46 <span type="species:ncbi:1773">Mtb</span>
###xml 208 211 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 248 251 <span type="species:ncbi:1773">Mtb</span>
###xml 342 345 <span type="species:ncbi:1773">Mtb</span>
###xml 597 619 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 688 693 <span type="species:ncbi:10090">mouse</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 1074 1077 <span type="species:ncbi:1773">Mtb</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
###xml 1321 1325 <span type="species:ncbi:10090">mice</span>
###xml 1411 1414 <span type="species:ncbi:1773">Mtb</span>
###xml 1437 1443 <span type="species:ncbi:9606">humans</span>
###xml 1445 1448 <span type="species:ncbi:1773">Mtb</span>
###xml 1495 1498 <span type="species:ncbi:1773">Mtb</span>
###xml 1700 1704 <span type="species:ncbi:10090">mice</span>
###xml 1709 1715 <span type="species:ncbi:9606">humans</span>
Infection with Mycobacterium tuberculosis (Mtb) remains an important cause of infectious disease, morbidity, and mortality worldwide [1] and has emerged as a major opportunistic infection in individuals with HIV/AIDS [2]. Control of infection with Mtb relies heavily on the cellular immune system, that is, the interaction of lymphocytes and Mtb-infected macrophages and dendritic cells (DCs) [3,4]. CD8+ T cells are associated with strong CD4+ TH1 cell responses, and are not only essential for effective immunity to viral pathogens, but also for immunity to some intracellular bacteria, such as Listeria monocytogenes and Salmonella species [5]. Increasing experimental evidence in the mouse tuberculosis (TB) model has suggested a protective role for CD8+ T cells in the host response. For example, adoptive transfer or in vivo depletion of CD8+ cells showed that this subset could confer protection against subsequent challenge [6-8]. beta2-microglobulin-deficient mice, deficient in expression of major histocompatibility complex (MHC) class I, are more susceptible to Mtb [9] and to large doses of Bacille Calmette Guerin [10] infection than their wild-type littermates. This finding has been corroborated in CD8-deficient mice [11] and other mice deficient in class I processing and presentation [11-13]. However, mice lacking class Ia-restricted CD8+ T cells demonstrate more moderate susceptibility to Mtb infection [14,15]. In humans, Mtb-specific CD8+ T cells have been identified in Mtb-infected individuals and include CD8+ T cells that are classically, MHC-Ia, restricted [16-22], and non-classically, MHC-Ib, restricted by HLA-E [18,23], and by CD1 [24-26]. Taken together, studies of mice and humans support an important role for CD8+ T cells in TB immunity.
###end p 6
###begin p 7
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b027">27</xref>
###xml 581 582 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b028">28</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b029">29</xref>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 877 878 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b019">19</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b020">20</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b030">30</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b034">34</xref>
###xml 1100 1107 1100 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1393 1400 1393 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b017">17</xref>
###xml 1440 1442 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b035">35</xref>
###xml 1539 1540 1539 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1712 1714 1712 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b017">17</xref>
###xml 1715 1717 1715 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b019">19</xref>
###xml 1718 1720 1718 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b034">34</xref>
###xml 2048 2049 2048 2049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2187 2194 2187 2194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 462 467 <span type="species:ncbi:9606">human</span>
###xml 492 495 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 517 520 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 572 577 <span type="species:ncbi:9606">human</span>
###xml 699 702 <span type="species:ncbi:1773">Mtb</span>
###xml 811 814 <span type="species:ncbi:1773">Mtb</span>
###xml 838 843 <span type="species:ncbi:9606">human</span>
###xml 941 944 <span type="species:ncbi:1773">Mtb</span>
###xml 1138 1141 <span type="species:ncbi:1773">Mtb</span>
###xml 1374 1377 <span type="species:ncbi:1773">Mtb</span>
###xml 1566 1569 <span type="species:ncbi:1773">Mtb</span>
###xml 1685 1692 <span type="species:ncbi:9606">persons</span>
###xml 1707 1710 <span type="species:ncbi:1773">Mtb</span>
###xml 1825 1828 <span type="species:ncbi:1773">Mtb</span>
###xml 1906 1913 <span type="species:ncbi:9606">persons</span>
###xml 2032 2035 <span type="species:ncbi:1773">Mtb</span>
###xml 2195 2198 <span type="species:ncbi:1773">Mtb</span>
For most infections, the repertoire of the CD8 response is shaped by the entry of antigen into the MHC-I processing pathway, binding of peptides and/or non-peptide antigens to MHC-I molecules, and recognition of these structures by T cells. Ultimately, a relatively limited subset of pathogen-specific T cells emerge, a process that has been termed immunodominance [27]. While substantial effort has focused on defining immunodominant CD8 antigens for important human viral pathogens such as HIV and cytomegalovirus (CMV), little is known about the antigens recognized by human CD8+ T cell in response to intracellular bacterial infections. Furthermore, although a number of commonly recognized CD4 Mtb antigens have been described [28,29] (ESAT-6, CFP10, Ag85, etc.), surprisingly little is known about common Mtb antigens recognized by human CD8+ T cells. The majority of CD8+ epitopes that have been identified were defined by testing of Mtb peptides selected for high-affinity binding to MHC class Ia molecules (HLA-A2 in most cases; [19,20,30-34]). In almost all of these examples, however, the ex vivo frequency of these T cells in Mtb-infected individuals is low or undetectable, suggesting that these specificities may not represent immunodominant responses. In contrast, in the limited cases in which T cells have been used to define epitopes contained in selected Mtb antigens, high ex vivo frequencies have been demonstrated [17,35], suggesting that a T cell-centered approach can identify immunodominant epitopes. Moreover, CD8+ T cell responses to some Mtb antigens that represent good CD4 antigens (CFP10, ESAT-6, Ag85, and Mtb39) have been detected at high frequency in persons infected with Mtb [17-19,34]. Therefore, we used a limited library of overlapping synthetic peptides representing several known CD4 Mtb antigens to determine the magnitude of the CD8 response to these antigens in persons with active TB and latent TB infection (LTBI), as well as uninfected individuals. Furthermore, we utilized a panel of Mtb-specific CD8+ T cell clones to define minimal epitopes recognized within these antigens and determined the contribution of these novel epitopes to the ex vivo Mtb-specific CD8 response.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 29 32 <span type="species:ncbi:1773">Mtb</span>
Definition of Immunodominant Mtb-Specific CD8 Antigens
###end title 9
###begin p 10
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b036">36</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b017">17</xref>
###xml 25 28 <span type="species:ncbi:1773">Mtb</span>
###xml 127 130 <span type="species:ncbi:1773">Mtb</span>
###xml 231 234 <span type="species:ncbi:1773">Mtb</span>
###xml 356 359 <span type="species:ncbi:1773">Mtb</span>
###xml 426 429 <span type="species:ncbi:1773">Mtb</span>
To define immunodominant Mtb-specific CD8 antigens, and to determine whether or not these responses result from infection with Mtb, we have used CD8+ T cells from uninfected donors, those with LTBI, or those actively infected with Mtb. Responses were determined either directly ex vivo, or using CD8+ T cell clones obtained by limiting dilution cloning on Mtb-infected autologous DCs [36]. As much is known about dominant CD4 Mtb antigens, a panel of these commonly recognized antigens was selected for further evaluation. These were Mtb39, CFP10, Mtb8.4, Mtb9.9A, ESAT-6, Ag85b, 19kDa, and EsxG. To avoid bias introduced by using peptides of predicted HLA binding specificity, we synthesized overlapping peptides (15 aa, overlap 11 aa) to represent the proteins of interest [17].
###end p 10
###begin p 11
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g001">Figure 1</xref>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 258 259 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
To accurately determine the ex vivo effector cell frequencies of CD8+ T cells, linear regression analysis was used. As shown in Figure 1, using D466 as an example, magnetic bead-purified CD8+ T cells were tested against peptide-pulsed DCs over a range of CD8+ T cell numbers in an IFN-gamma ELISPOT assay. A positive assay was determined as described below and if positive, the antigen-specific frequency was determined using linear regression.
###end p 11
###begin title 12
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex Vivo</italic>
###xml 17 22 <span type="species:ncbi:9606">Human</span>
Determination of Human Effector Cell Frequencies Ex Vivo Using the IFN-gamma ELISPOT Assay
###end title 12
###begin p 13
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 121 124 <span type="species:ncbi:1773">Mtb</span>
###xml 1036 1039 <span type="species:ncbi:1773">Mtb</span>
Magnetic bead-purified CD8+ T cells from a single donor (D466) were cultured with DCs (20,000/well) either infected with Mtb (H37Rv, multiplicity of infection = 50) or pulsed with peptide pool representing CFP10 (5 mug/ml each peptide; 15-mer overlap by 11 aa) in an IFN-gamma ELISPOT assay. Each responding T cell population was tested in duplicate at four different cell concentrations. To determine the effector cell frequency of antigen-specific T cells, the average number of spot forming units per well for each duplicate was plotted against the number of responder cells per well. Linear regression analysis was used to determine the slope of the line, which represents the frequency of antigen-specific T cells. The assay was considered positive, reflecting the presence of a primed T cell response, if the binomial probability for the number of spots was significantly different by experimental and control assays, i.e., if the experimental line is statistically significantly different from the control line. The frequency of Mtb-specific and CFP10-specific T cells demonstrated in this figure was 1/307 and 1/1676, respectively.
###end p 13
###begin p 14
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 359 360 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 369 377 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g002">Figure 2</xref>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t001">Table 1</xref>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 677 685 677 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g002">Figure 2</xref>
###xml 726 733 726 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t001">Table 1</xref>
###xml 763 764 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 876 877 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1021 1022 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 140 143 <span type="species:ncbi:1773">Mtb</span>
###xml 180 183 <span type="species:ncbi:1773">Mtb</span>
###xml 257 260 <span type="species:ncbi:1773">Mtb</span>
###xml 436 439 <span type="species:ncbi:1773">Mtb</span>
###xml 502 505 <span type="species:ncbi:1773">Mtb</span>
###xml 575 578 <span type="species:ncbi:1773">Mtb</span>
###xml 1005 1008 <span type="species:ncbi:1773">Mtb</span>
Uninfected individuals (n = 14), those with LTBI (n = 20), and those with active TB (n = 12) were evaluated for CD8 responses to a panel of Mtb CD4+ T cell antigens, as well as to Mtb-infected DCs. All individuals tested had robust CD8+ T cell responses to Mtb-infected DCs and were of greater magnitude in individuals with active TB than in those with LTBI (p = 0.01; Figure 2; Table 1). However, CD8+ T cell responses to the panel of Mtb antigens were found almost exclusively in those infected with Mtb in that statistically significant differences between uninfected and Mtb-infected individuals were noted for seven of ten antigens for both the magnitude of the response (Figure 2) and the proportion of positive assays (Table 1). However, differences in CD8+ T cell responses between individuals with active TB and LTBI were not statistically different. While strong CD8+ T cell responses were observed against many of the antigens tested, it is equally notable that several individuals with strong Mtb-directed CD8+ T cell responses did not have demonstrable responses to many of the antigens tested (unpublished data).
###end p 14
###begin title 15
###xml 5 12 5 12 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Ex vivo</named-content>
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 40 43 <span type="species:ncbi:1773">Mtb</span>
###xml 73 76 <span type="species:ncbi:1773">Mtb</span>
High Ex vivo CD8+ T Cell Frequencies to Mtb Antigens Are Associated with Mtb Infection
###end title 15
###begin p 16
###xml 6 14 6 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g001">Figure 1</xref>
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 466 467 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 477 478 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 488 489 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 501 502 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 825 826 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 839 840 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 855 856 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 885 886 881 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 899 900 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 915 916 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 946 947 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 960 961 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 976 977 972 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1000 1001 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1014 1015 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1030 1031 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1055 1056 1051 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1069 1070 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1085 1086 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1111 1112 1107 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1125 1126 1121 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1141 1142 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1165 1166 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1179 1180 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1195 1196 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1224 1225 1220 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1238 1239 1234 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1254 1255 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1283 1284 1279 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1297 1298 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1313 1314 1309 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1336 1337 1332 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1350 1351 1346 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1366 1367 1362 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1392 1393 1388 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1406 1407 1402 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1422 1423 1418 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1430 1431 1426 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1519 1520 1515 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 98 101 <span type="species:ncbi:1773">Mtb</span>
###xml 118 121 <span type="species:ncbi:1773">Mtb</span>
###xml 183 186 <span type="species:ncbi:1773">Mtb</span>
###xml 548 551 <span type="species:ncbi:1773">Mtb</span>
###xml 686 689 <span type="species:ncbi:1773">Mtb</span>
###xml 802 805 <span type="species:ncbi:1773">Mtb</span>
As in Figure 1, to determine ex vivo CD8+ T cell frequencies, autologous DCs either infected with Mtb (graph labeled "Mtb DC") or pulsed with cognate peptide pools representing known Mtb CD4 antigens (all other graphs) were incubated with CD8+ T cells in an IFN-gamma ELISPOT assay. The number of spot forming units (SFU)/250,000 cells is shown, a number which is derived from linear regression analysis of the frequency of T cells tested at concentrations of 5 x 105, 2.5 x 105, 1.2 x 105, and 6 x 104 cells/well. Individuals without evidence for Mtb infection ("normal"); those with LTBI, and those with active TB ("active" defined as culture confirmed pulmonary TB) were evaluated. "Mtb Infected" includes both the "LTBI" and "active" groups. The number of individuals tested for each antigen were: Mtb infection (normal, n = 11; LTBI, n = 11; active, n = 6); Mtb39 Pool A (normal, n = 14; LTBI, n = 20; active, n = 10); Mtb39 Pool B (normal, n = 14; LTBI, n = 20; active, n = 10); CFP10 (normal, n = 14; LTBI, n = 20; active, n = 10); Mtb8.4 (normal, n = 14; LTBI, n = 20; active, n = 10); Mtb9.9A (normal, n = 14; LTBI, n = 20; active, n = 5); ESAT-6 (normal, n = 14; LTBI, n = 20; active, n = 5); Ag85 Pool A (normal, n = 14; LTBI, n = 17; active, n = 5); Ag85 Pool B (normal, n = 14; LTBI, n = 17; active, n = 5); 19kDa (normal, n = 12; LTBI, n = 17; active, n = 5); and EsxG (normal, n = 14; LTBI, n = 17; active, n = 5). p-Values are noted where statistically significant differences between groups are noted (p = <0.05; Wilcoxon/Kruskal-Wallis).
###end p 16
###begin p 17
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD8+ T Cell Responses to Known TB Antigens
###end p 17
###begin title 18
###xml 48 51 <span type="species:ncbi:1773">Mtb</span>
Definition of the Minimal Epitope Recognized by Mtb-Specific CD8+ T Cell Clones
###end title 18
###begin p 19
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b036">36</xref>
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 605 612 605 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t002">Table 2</xref>
###xml 754 762 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g003">Figure 3</xref>
###xml 1046 1050 1046 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;15</sub>
###xml 1052 1060 1052 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g003">Figure 3</xref>
###xml 1209 1217 1209 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g003">Figure 3</xref>
###xml 1341 1349 1341 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g003">Figure 3</xref>
###xml 1531 1532 1531 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1691 1699 1691 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g004">Figure 4</xref>
###xml 1813 1817 1813 1817 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;12</sub>
###xml 1928 1936 1928 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g005">Figure 5</xref>
###xml 2042 2049 2042 2049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t003">Table 3</xref>
###xml 104 107 <span type="species:ncbi:1773">Mtb</span>
###xml 305 310 <span type="species:ncbi:9606">human</span>
###xml 330 333 <span type="species:ncbi:1773">Mtb</span>
These ex vivo frequency data demonstrated the presence of high-frequency responses to a number of known Mtb antigens, but did not shed light on the restricting allele, minimal epitope, or dominance hierarchy within the gene of interest. To address this question, we performed limiting dilution cloning of human CD8+ T cells using Mtb-infected DCs [36], and generated panels of both classically and non-classically HLA-restricted CD8+ T cell clones. Using peptide pools representing known CD4 antigens, the antigenic specificity of the HLA-Ia-restricted clones was defined in more than half of the clones (Table 2). This approach is demonstrated in detail for a single representative clone, D466 D6, derived from an individual with active TB. As shown in Figure 3A, testing the clone against autologous DCs pulsed with a panel of peptide pools unambiguously defined the antigenic specificity as CFP10. The clone was then tested against each of the 15-mer peptides that comprise the CFP10 pool, revealing that the epitope was contained within CFP101-15 (Figure 3B). Each possible 8-aa, 9-aa, 10-aa, and 11-aa peptide was then synthesized and tested for reactivity, revealing antigenic activity between aa 2-11 (Figure 3C). Similarly, each clone was tested against lymphoblastoid cell lines (LCLs) sharing at least one HLA type with the donor (Figure 3D). Autologous LCL and IHW 9058 LCL, which share B4501 and C1601, presented the epitope to the clone, identifying both B4501 and C1601 as possible restricting alleles. However, C1601+ D433 LCL did not present the epitope, eliminating C1601 as a candidate-restricting allele. Therefore, D466 D6 was restricted by HLA-B4501. As demonstrated in Figure 4, by testing each plausible epitope over a broad range of concentrations, the minimal epitope was defined as CFP102-12 for D466 D6. Experimental data supporting the assignment of the minimal epitope is provided for each clone in Figure 5, and a summary of the antigenic specificity, minimal epitope, and HLA-restricting allele is presented in Table 3. Unexpectedly, all but one of the T cell clones were restricted by HLA-B alleles. Furthermore, a minority of those observed were 9 aa in length.
###end p 19
###begin p 20
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Many CD8+ T Cell Clones Recognize Known CD4 Antigens
###end p 20
###begin title 21
Definition of Antigenic Specificity and HLA Restriction: Characterization of T Cell Clone D466 D6
###end title 21
###begin p 22
(A-C) To identify the antigen and minimal epitope recognized by T cell clone D466 D6, T cells (5,000 cells/well) were incubated with autologous LCL (20,000/well) and antigen (5 mug/ml). Negative controls (media, no antigen) and positive controls (phytohemagglutanin [PHA], final, 10 mug/ml) are shown for each assay. IFN-gamma was assessed by ELISPOT after 18 h of co-culture. Pictures of ELISPOT wells are shown.
###end p 22
###begin p 23
###xml 63 66 <span type="species:ncbi:1773">Mtb</span>
(A) Antigens consisted of peptide pools representing known CD4 Mtb antigens, made up of 15-aa peptides overlapping by 11 aa.
###end p 23
###begin p 24
(B) Antigens consisted of individual 15-aa CFP10 peptides that together constitute the peptide pool.
###end p 24
###begin p 25
###xml 65 69 65 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;15</sub>
(C) Antigens consisted of individual nested peptides within CFP101-15 (10 aa, 9 aa, or 8 aa), used to further map the epitope.
###end p 25
###begin p 26
###xml 196 200 196 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;10</sub>
(D) The restricting allele was identified using LCLs (20,000/well) that were either autologous or expressing HLA alleles matching D466 at one or two alleles (shown in bold font), pulsed with CFP102-10 (5 mug/ml) as APC. Autologous LCLs without peptide (control) are also shown. After 2 h, cells were washed and incubated with T cells (500 cells/well) in an IFN- gamma ELISPOT assay. Pictures of ELISPOT wells are shown.
###end p 26
###begin title 27
Confirmation of Minimal Epitope Mapping of D466 D6
###end title 27
###begin p 28
To confirm the minimal epitope, autologous LCLs (20,000/well) were pulsed with peptide at the concentration indicated and co-cultured with T cells (1,000 cells/well). IFN-gamma was assessed by ELISPOT after 18 h co-culture. Each point represents the mean of duplicate determinations.
###end p 28
###begin title 29
Summary of Minimal Epitope Mapping Data
###end title 29
###begin p 30
To determine the minimal epitope, autologous LCLs (20,000/well) were pulsed with peptide at the concentration indicated and co-cultured with T cells (1,000 cells/well). IFN-gamma was assessed by ELISPOT after 18 h co-culture. Each point represents the mean of duplicate determinations.
###end p 30
###begin p 31
Summary of CD8+ T Cell Epitopes Identified
###end p 31
###begin title 32
Immunodominance of MTb CD8 Epitopes in Infected Individuals
###end title 32
###begin p 33
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 224 231 224 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 474 481 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g001">Figure 1</xref>
###xml 608 609 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 700 707 700 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 767 774 767 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t003">Table 3</xref>
###xml 925 926 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1045 1046 1045 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1177 1178 1177 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1308 1309 1308 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1682 1683 1682 1683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1927 1935 1927 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g006">Figure 6</xref>
###xml 1941 1948 1941 1948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 2244 2251 2244 2251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t003">Table 3</xref>
###xml 2601 2608 2601 2608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t003">Table 3</xref>
###xml 97 100 <span type="species:ncbi:1773">Mtb</span>
###xml 853 856 <span type="species:ncbi:1773">Mtb</span>
###xml 1029 1032 <span type="species:ncbi:1773">Mtb</span>
###xml 1161 1164 <span type="species:ncbi:1773">Mtb</span>
###xml 1292 1295 <span type="species:ncbi:1773">Mtb</span>
###xml 1462 1465 <span type="species:ncbi:1773">Mtb</span>
Because each of the individual CD8+ T cell clones was derived based on growth in the presence of Mtb- infected DCs, we sought to determine whether or not the antigen and epitopes identified reflected immunodominant epitopes ex vivo. Two independent approaches were pursued, the first to determine if the response was present at high frequency, and the second to determine what proportion of the total response to the antigen was constituted by the epitope. To determine the ex vivo effector cell frequency, as described in Figure 1, each epitope was tested using autologous DCs and magnetic bead-purified CD8+ T cells derived from the donor from whom the T cell clones was isolated. A summary of the ex vivo epitope-specific effector cell frequencies is presented in Table 3. For comparison, effector cell frequencies using autologous DCs infected with Mtb as the antigen-presenting cells (APCs) are shown as well. For 11 CD8+ T cell clones recognizing distinct epitopes, the epitope-specific frequency exceeded 50% of the total Mtb-specific CD8+ T cell response. For six of these clones, the epitope-specific frequency actually exceeded the total frequency of Mtb-specific CD8+ T cells. Conversely, for two clones, the epitope-specific T cell frequency constituted the minority of the total Mtb-specific CD8+ T cell response. Thus, overall, the epitopes reflected high-frequency responses, and could be considered a response that has been primed by exposure to Mtb. Notably, T cell clones isolated from four donors recognized CFP10. To determine if the epitopes defined reflected a substantial proportion of the total response to the antigen of interest, magnetic bead-purified CD8+ T cells from three donors with sufficient available peripheral blood mononuclear cells (PBMCs) were tested for reactivity to each individual 15-mer peptide, the peptide pool, and peptide representing the minimal epitope. As is demonstrated in Figure 6, the ex vivo frequencies to the minimal epitope, 15-mer peptide(s) containing the minimal epitope, and peptide pool were remarkably concordant. These data, then, suggest that for each donor a dominance hierarchy has been clearly established, and was reflected in the original clones. Finally, as is noted in Table 3, daughter clones of identical specificity were frequently identified, a result that would be predicted based on an immundominance hierarchy. TCR V beta staining was used to confirm the clonal relationship between daughter clones. Interestingly, in two cases, the identical minimal epitope and HLA restriction was represented by two distinct clones (Table 3).
###end p 33
###begin title 34
Profiling of Immunodominance Pattern for CFP10
###end title 34
###begin p 35
###xml 276 280 274 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;11</sub>
###xml 292 296 290 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8211;11</sub>
###xml 308 313 306 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">75&#8211;83</sub>
###xml 379 380 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
To determine the effector cell frequencies, autologous DCs (20,000/well) were pulsed either with each individual 15-mer peptide (5 mug/ml), the peptide pool (PP; 5 mug/each peptide), or the minimal epitope (ME) determined from T cell clones derived from each donor (D466:CFP102-11; D480:CFP103-11; D481:CFP1075-83; 5 mug/ml), and tested against 250,000 magnetic bead-purified CD8+ T cells. IFN-gamma release was assessed by ELISPOT after 18 h of co-culture. Each point represents the mean of duplicate determinations.
###end p 35
###begin title 36
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
HLA Binding Affinity to CD8+ T Cell Epitopes
###end title 36
###begin p 37
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 625 627 625 627 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 777 785 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030127-st001">Table S1</xref>
###xml 797 804 797 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t003">Table 3</xref>
###xml 814 816 814 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1039 1047 1039 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g005">Figure 5</xref>
###xml 1049 1057 1049 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030127-st001">Table S1</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 52 55 <span type="species:ncbi:1773">Mtb</span>
###xml 756 761 <span type="species:ncbi:9606">human</span>
Because much work on human CD8+ T cell responses to Mtb has relied upon the use of HLA prediction algorithms, as each epitope was defined we asked whether or not the epitopes would have been predicted by these approaches. Given the prevalence of HLA-B alleles and 10-mer and 11-mer epitopes, it is perhaps not surprising that many of these epitopes were not ranked strongly (unpublished data). This left open the possibility that either HLA binding was indeed not predictive of antigenicity, or simply highlighted the limitations of those algorithms at the time they were used. To address this question experimentally, the IC50 for each peptide that had been synthesized in the course of definition of the minimal epitope was determined against a panel of human HLA molecules (Table S1). Shown in Table 3 is the IC50 for the minimal epitope with the cognate restricting allele. These data demonstrate that the T cell epitopes bound avidly to HLA, and show a high degree of concordance between the T cell epitope data and HLA binding data (Figure 5; Table S1).
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b037">37</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b038">38</xref>
###xml 505 512 505 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 590 591 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 839 840 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1032 1033 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1130 1131 1130 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 64 <span type="species:ncbi:1773">Mtb</span>
###xml 185 192 <span type="species:ncbi:9606">persons</span>
###xml 207 210 <span type="species:ncbi:1773">Mtb</span>
###xml 331 334 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 652 655 <span type="species:ncbi:1773">Mtb</span>
###xml 786 789 <span type="species:ncbi:1773">Mtb</span>
###xml 861 864 <span type="species:ncbi:1773">Mtb</span>
###xml 1045 1048 <span type="species:ncbi:1773">Mtb</span>
###xml 1275 1278 <span type="species:ncbi:1773">Mtb</span>
Although the complete repertoire of CD8+ T cell responses in Mtb remains incompletely characterized, the following conclusions can be drawn. First, CD8+ T cell responses are present in persons infected with Mtb at frequencies that are comparable to that seen following many common viral infections such as vaccinia, influenza, and CMV [37,38]. This conclusion is based both on the pooled peptide experiments described above, and on the observation that when defined, dominant epitopes are present at high ex vivo frequencies. Conversely, we have not observed high-frequency responses to CD4+ T cell antigens in those without evidence of infection with Mtb. This observation strongly supports the hypothesis that these responses reflect an adaptively acquired response to infection with Mtb, rather than an innate response. By contrast, CD8+ T cell responses to Mtb-infected DCs were equivalent in infected and uninfected individuals. Using limiting dilution analysis, we have studied the proportions of Ia- versus Ib- restricted CD8+ T cells in Mtb-infected compared to uninfected individuals and have noted that Ib-restricted CD8+ T cell responses predominate in uninfected individuals (D. Lewinsohn, unpublished data). Therefore, we speculate that the response detected to Mtb-infected DCs in uninfected individuals may reflect chiefly a Ib-restricted response. While we did not observe an association of responses to specific antigens with disease status, a larger study might reveal more subtle differences.
###end p 39
###begin p 40
###xml 531 538 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 646 654 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030127-g006">Figure 6</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b039">39</xref>
###xml 1303 1305 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b040">40</xref>
###xml 1334 1336 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b041">41</xref>
###xml 374 377 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 686 689 <span type="species:ncbi:1773">Mtb</span>
###xml 748 751 <span type="species:ncbi:1773">Mtb</span>
###xml 838 841 <span type="species:ncbi:1773">Mtb</span>
###xml 933 936 <span type="species:ncbi:1773">Mtb</span>
###xml 1041 1044 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1227 1232 <span type="species:ncbi:9606">Human</span>
###xml 1740 1745 <span type="species:ncbi:9606">human</span>
All but one of the epitopes that have been mapped to date are restricted by HLA-B molecules. The reasons for this possible skewing are not yet clear. It is a formal possibility that the cloning methods we used biased isolation of HLA-B- over HLA-A-restricted T cell clones. However, using identical cloning methodology, we have isolated T cell clones specific for vaccinia, CMV, and influenza that did not display a preference for HLA-B restriction (D. Lewinsohn, unpublished data). Furthermore, in all three cases where we tested ex vivo the entire set of peptides representing CFP10, the entire response mapped to the HLA-B-restricted epitope (Figure 6). Therefore, we speculate that Mtb antigens may preferentially bind to HLA-B molecules, that Mtb preferentially interferes with HLA-A processing and presentation, that infection with Mtb leads to selective upregulation of HLA-B, or that HLA-B is preferentially delivered to the Mtb phagosome. Nonetheless, these data are consistent with those reported by Kiepiela et al. [39], in which HIV-specific T cell responses were found to be 2.5-fold more likely to be HLA-B- than HLA-A-restricted, and observed that viral load was more closely linked to HLA-B than HLA-A alleles. Human infection with mycobacteria has been demonstrated in pre-urban Egypt [40] and in pre-Columbian Peru [41], observations consistent with the hypothesis that mycobacterial infection has driven the diversity and peptide-binding repertoire of the HLA-B locus. Furthermore, our data is consistent with the hypothesis that the diversity of HLA-B alleles is related to the containment of both viral and bacterial pathogens. Hence, delineation of immunodominant epitopes and antigens within the context of important human pathogens will likely require careful evaluation of those epitopes presented by HLA-B.
###end p 40
###begin p 41
###xml 506 513 506 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030127-t003">Table 3</xref>
###xml 715 719 715 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;11</sub>
###xml 421 424 <span type="species:ncbi:1773">Mtb</span>
While the immune response within an individual to a given antigen is narrowly focused, dominant epitopes that would be useful for population-based analysis have yet to be defined. This conclusion is based on the fact that few of the HLA-A2 epitopes described to date have proved to be widely recognized, and, most importantly, on the observation that a wide variety of HLA alleles appear to be used in the recognition of Mtb antigens. The antigen CFP10 is an excellent case in point. As is demonstrated in Table 3, T cell clones have been used to define high-frequency epitopes restricted by a variety of HLA alleles. While the N-terminal 15 aa could reasonably be considered immunogenic, in all but one case (CFP102-11; HLA-B44) the minimal epitope defined has been unique to the individual from whom the T cells were derived.
###end p 41
###begin p 42
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 107 113 <span type="species:ncbi:9606">humans</span>
###xml 128 131 <span type="species:ncbi:1773">Mtb</span>
###xml 298 301 <span type="species:ncbi:1773">Mtb</span>
###xml 450 453 <span type="species:ncbi:1773">Mtb</span>
###xml 512 515 <span type="species:ncbi:1773">Mtb</span>
###xml 617 620 <span type="species:ncbi:1773">Mtb</span>
###xml 869 872 <span type="species:ncbi:1773">Mtb</span>
###xml 986 989 <span type="species:ncbi:1773">Mtb</span>
By using a T cell-driven approach to epitope identification, it is possible to define dominant epitopes in humans infected with Mtb. While it is striking that for several of the T cell clones the ex vivo frequency of epitope-specific T cells was equal to or exceeded the total ex vivo frequency of Mtb-specific T cells, we acknowledge that the use of peptide-loaded DCs to determine T cell frequency likely overrepresents the proportion of the total Mtb-specific CD8+ T cell responses. Possible reasons are that Mtb infection is likely to produce relatively less cognate peptide compared to peptide loading, and that Mtb infection could possibly interfere with class I processing and presentation. Although the current observations are limited to a small panel of known CD4 antigens, current work is underway to perform a genome-wide survey of dominant CD8 antigens in Mtb. Definition of this panel will likely prove useful in the further study of the natural history of infection with Mtb and in the design of novel vaccines and diagnostics.
###end p 42
###begin p 43
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b042">42</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b043">43</xref>
In TB, evaluation of epitopes based strictly on HLA binding algorithms has focused on HLA-A2, and has often failed to define dominant epitopes. Our observation that many of the epitopes are HLA-B restricted, and often longer than 9 aa, for which these algorithms are less robust, may help explain these findings. However, when evaluated experimentally, all of the minimal epitopes exhibit high-affinity binding to the cognate-restricting allele. In this regard, substantial progress in HLA prediction algorithms is evident [42,43], and could facilitate more efficient identification of dominant epitopes. Here, more information with regard to longer peptides will be of benefit. Finally, we speculate that these caveats are likely to apply to other intracellular pathogens as well.
###end p 43
###begin p 44
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b044">44</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b038">38</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b045">45</xref>
###xml 61 67 <span type="species:ncbi:9606">humans</span>
###xml 136 139 <span type="species:ncbi:1773">Mtb</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
###xml 824 827 <span type="species:ncbi:1773">Mtb</span>
###xml 904 907 <span type="species:ncbi:1773">Mtb</span>
###xml 1029 1032 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1255 1258 <span type="species:ncbi:1773">Mtb</span>
###xml 1414 1417 <span type="species:ncbi:1773">Mtb</span>
###xml 1579 1582 <span type="species:ncbi:1773">Mtb</span>
###xml 1652 1655 <span type="species:ncbi:1773">Mtb</span>
One limitation to current knowledge is that the responses in humans have been made at a single time point. In this regard, a feature of Mtb is the chronic exposure to antigen that may persist for many years. How this chronic infection influences the shaping of the immune response and dominance repertoire is an important question that remains unresolved. The advent of new reagents for immunologic studies in the mouse model [44] will likely be useful in this regard. For example, chronic antigenic exposure seems likely to alter the affinity of the T cell response over time. Furthermore, it is possible that such long-term infection might lead to clonal exhaustion or dysfunction as has been described for chronic viral infection [38]. Finally, given the very high-frequency responses that we and others have observed to Mtb-infected DCs and to single antigens, it appears that the immune response to Mtb occupies a sizable fraction of the host's immunological activity, similar to that previously observed for infection with CMV [45]. If so, then this may have important implications for the aging immune system, and potentially for the requirements for the long-term containment of intracellular infection. For example, it is possible that threshold Mtb-specific CD8 frequencies are necessary for the maintenance of a state of chronic persistence. Conversely, the substantial immunological effort directed at Mtb may limit the host's ability to effectively combat novel infections. As a result, this static picture leaves open important questions as to the evolution of the Mtb-specific responses, and its relationship with chronic infection with Mtb.
###end p 44
###begin p 45
###xml 355 357 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b046">46</xref>
###xml 358 360 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b049">49</xref>
###xml 21 24 <span type="species:ncbi:1773">Mtb</span>
###xml 225 228 <span type="species:ncbi:1773">Mtb</span>
###xml 411 414 <span type="species:ncbi:1773">Mtb</span>
It seems likely that Mtb has evolved potent mechanisms to modulate the immune response. At present, specific mechanisms for MHC-I immune modulation have not been described. However, it appears that TLR II stimulation via the Mtb-derived 19-kDa lipoprotein can modulate both MHC-I and MHC-II antigen processing, and can interfere with IFN-gamma signaling [46-49]. Further work on the T cell subsets important in Mtb, including the immunodominant epitopes, will extend our understanding of the immunology of TB and potentially contribute to the development of a vaccine against this major killer.
###end p 45
###begin p 46
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 356 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 448 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 8 11 <span type="species:ncbi:1773">Mtb</span>
###xml 90 93 <span type="species:ncbi:1773">Mtb</span>
###xml 205 208 <span type="species:ncbi:1773">Mtb</span>
###xml 483 486 <span type="species:ncbi:1773">Mtb</span>
How the Mtb-specific CD8+ T cell response fits into the natural history of infection with Mtb remains poorly characterized. For example, the ontogeny of the CD8+ T cell response relative to infection with Mtb remains unknown, as does the relationship of CD8+ T cell frequencies with regard to bacterial burden. However, by defining commonly recognized CD8+ T cell antigens and epitopes, it will become increasingly possible to employ direct ex vivo analysis to more precisely define Mtb-specific T cell responses in various subject groups of particular interest.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants.
###end title 48
###begin p 49
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b036">36</xref>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 174 186 <span type="species:ncbi:9606">participants</span>
###xml 478 481 <span type="species:ncbi:1773">Mtb</span>
###xml 529 536 <span type="species:ncbi:9606">persons</span>
###xml 1013 1016 <span type="species:ncbi:1773">Mtb</span>
Study participants, protocols, and consent forms were approved by the Oregon Health and Science University institutional review board. Informed consent was obtained from all participants. Uninfected individuals and individuals with LTBI were recruited from employees at Oregon Health and Science University as previously described [36]. Uninfected individuals were defined as healthy individuals with a negative tuberculin skin test and no known risk factors for infection with Mtb. Individuals with LTBI were defined as healthy persons with a positive tuberculin skin test and no symptoms and signs of active TB. Individuals with active TB were recruited via institutional review board-approved advertisement and were self-referred from the Multnomah County TB Clinic, Portland, Oregon, United States, or from the Washington County TB Clinic, Hillsboro, Oregon, United States. In all active TB cases, pulmonary TB was diagnosed by the TB Controller of these counties and confirmed by positive sputum culture for Mtb. PBMCs were isolated from whole blood obtained by venipuncture or apheresis.
###end p 49
###begin title 50
Media and reagents.
###end title 50
###begin p 51
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b036">36</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b050">50</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b051">51</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b052">52</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b053">53</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b054">54</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b016">16</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b055">55</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b056">56</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b057">57</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b058">58</xref>
###xml 66 72 <span type="species:ncbi:9913">bovine</span>
###xml 193 196 <span type="species:ncbi:1773">Mtb</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 270 273 <span type="species:ncbi:1773">Mtb</span>
###xml 519 522 <span type="species:ncbi:1773">Mtb</span>
###xml 672 675 <span type="species:ncbi:1773">Mtb</span>
Culture medium consisted of RPMI 1640 supplemented with 10% fetal bovine sera (BioWhittaker, ), 5 x 10-5 M 2 ME (Sigma-Aldrich, ), and 2 mM glutamine (GIBCO BRL, ). For the growth and assay of Mtb-reactive T cell clones, RPMI 1640 was supplemented with 10% human serum. Mtb strain H37Rv was obtained from the American Type Culture Collection () and prepared as previously described [36]. Peptides were synthesized by Genemed Synthesis (). Synthetic peptide pools consisted of 15 mers overlapping by 11 aa, representing Mtb proteins demonstrated to be potent CD4 antigens. Peptide pools representing CFP10 [50,51], ESAT-6 [52], Mtb39a (two pools, A & B) [53], Mtb8.4 [54], Mtb 9.9A [16], EsxG [55,56], 19kDa antigen [57], and antigen 85b (two pools, A & B) [58] were synthesized. Peptides were resuspended in DMSO, and up to 50 peptides were combined into one pool such that each peptide in the pool was at a concentration of 1 mg/ml. Peptide pools were stored at -80 degreesC.
###end p 51
###begin title 52
Cell lines and T cell clones.
###end title 52
###begin p 53
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b018">18</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b036">36</xref>
###xml 480 481 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 979 980 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 283 286 <span type="species:ncbi:1773">Mtb</span>
###xml 371 374 <span type="species:ncbi:1773">Mtb</span>
###xml 1003 1006 <span type="species:ncbi:1773">Mtb</span>
###xml 1149 1154 <span type="species:ncbi:9606">human</span>
###xml 1219 1222 <span type="species:ncbi:1773">Mtb</span>
###xml 1253 1256 <span type="species:ncbi:1773">Mtb</span>
###xml 1309 1312 <span type="species:ncbi:1773">Mtb</span>
EBV-transformed B cell lines, LCLs, were either generated in our laboratory using supernatants from the cell line 9B5-8 (American Type Culture Collection) or obtained from the National Marrow Donor Program (). LCLs were maintained by continuous passage as previously described [18]. Mtb-specific T cell clones were isolated from individuals with LTBI or active TB, using Mtb-infected DCs as APCs and limiting dilution cloning methodology as previously described [36]. Briefly, CD8+ T cells were isolated from PBMCs using negative selection using CD4 antibody-coated beads and then positive selection using CD8 antibody-coated magnetic beads per the manufacturer's instructions (Miltenyi Biotec, ) or via flow cytometry. In this case, CD4-PE (BD Biosciences, catalog #555347; ) negative and CD8-APC (BD Biosciences, catalog #555369) positive cells (purity >99%) were sorted on a Becton Dickinson LSR II (). T cells were seeded at various concentrations in the presence of a 1 x 105-irradiated autologous Mtb-infected DC, generated as described below, and rIL-2 (5 ng/ml) in cell culture media consisting of 200 mul of RPMI 1640 supplemented with 10% human sera. Wells exhibiting growth between 10-14 d were assessed for Mtb specificity using ELISPOT and Mtb-infected DCs as a source of APCs. T cells retaining Mtb specificity were further phenotyped for alphabeta T cell receptor expression and CD8 expression by FACS and expanded as described below. V beta usage was determined using the IOTest Beta Mark Kit from Beckman Coulter, catalog #IM3497 ().
###end p 53
###begin title 54
Expansion of T cell clones.
###end title 54
###begin p 55
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b018">18</xref>
To expand the CD8+ T cell clones, a rapid expansion protocol using anti-CD3 mAb stimulation was used as described previously [18].
###end p 55
###begin title 56
Generation and infection of peripheral blood DCs.
###end title 56
###begin p 57
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b018">18</xref>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b059">59</xref>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b060">60</xref>
###xml 104 107 <span type="species:ncbi:1773">Mtb</span>
###xml 181 184 <span type="species:ncbi:1773">Mtb</span>
###xml 307 310 <span type="species:ncbi:1773">Mtb</span>
###xml 501 506 <span type="species:ncbi:9606">human</span>
Monocyte-derived DCs were prepared according to a modified method of Romani et al. [18,59]. To generate Mtb-infected DCs, cells (1 x 106) were cultured overnight in the presence of Mtb at a multiplicity of infection = 50:1. We have determined that this multiplicity of infection is optimal for detection of Mtb-specific CD8+ T cells, as heavy infection is required to optimize entry of antigen into the class I processing pathway [60]. After 18 h, the cells were harvested and resuspended in RPMI/10% human serum.
###end p 57
###begin title 58
MHC binding assays.
###end title 58
###begin p 59
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b061">61</xref>
###xml 1042 1044 1039 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1071 1073 1066 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 339 344 <span type="species:ncbi:9606">human</span>
The MHC peptide binding assay utilized measures the ability of peptide ligands to inhibit the binding of a radiolabeled peptide to purified MHC molecules, and has been described in detail elsewhere [61] . Briefly, purified MHC molecules, test peptides, and a radiolabeled probe peptide are incubated at room temperature in the presence of human beta2-microglobulin and a cocktail of protease inhibitors. After a 2-d incubation, binding of the radiolabeled peptide to the corresponding MHC class I molecule is determined by capturing MHC/peptide complexes on W6/32 antibody (anti-HLA A, B, and C) or B123.2 (anti-HLA B, C, and some A) coated plates, and measuring bound cpm using a microscintillation counter. For competition assays, the concentration of peptide yielding 50% inhibition of the binding of the radiolabeled peptide is calculated. Peptides are typically tested at six different concentrations covering a 100,000-fold dose range, and in three or more independent assays. Under the conditions utilized, where [label] < [MHC] and IC50 >/= [MHC], the measured IC50 values are reasonable approximations of the true Kd values.
###end p 59
###begin title 60
IFN-gamma ELISPOT assay.
###end title 60
###begin p 61
###xml 67 69 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b018">18</xref>
###xml 93 100 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 119 120 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 178 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 308 309 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 328 329 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 450 451 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 461 462 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 472 473 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 485 486 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 143 146 <span type="species:ncbi:1773">Mtb</span>
###xml 160 163 <span type="species:ncbi:1773">Mtb</span>
###xml 588 591 <span type="species:ncbi:1773">Mtb</span>
The IFN-gamma ELISPOT assay was performed as described previously [18]. For determination of ex vivo frequencies of CD8+ T cells responding to Mtb infection or Mtb antigens, CD8+ T cells were positively selected from PBMCs using magnetic beads (Miltenyi Biotec) such that >97% of the cell population were CD8+ T cells. These CD8+ T cells were used as a source of responder T cells and tested in duplicate at four different cell concentrations (5 x 105, 2.5 x 105, 1.2 x 105, and 6 x 104 cells/well). Autologous DCs (20,000 cells/well) were used as APCs, and DCs were either infected with Mtb or pulsed with peptide pools (5 mug/ml, final concentration of each peptide) and then added to the assay. For assays using T cell clones, T cells (1,000 or 5,000 cells/well) were incubated with autologous LCL (20,000 cells/well) in the presence or absence of antigen. Negative and positive controls were included in each assay and consisted of wells containing T cells and DCs either without antigen or without antigen but with inclusion of phytohemagglutanin (PHA, 10 mug/ml; EMD Biosciences, ), respectively. For all assays, responding T cells were incubated with APCs overnight.
###end p 61
###begin title 62
Data analysis.
###end title 62
###begin p 63
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030127-b062">62</xref>
###xml 648 655 648 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
To determine the ex vivo frequency of antigen-specific T cells, the average number of spots per well for each duplicate was plotted against the number of responder cells per well. Linear regression analysis was used to determine the slope of the line, which represents the frequency of antigen-specific T cells. The assay is considered positive, i.e., reflecting the presence of a primed T cell response, if the binomial probability [62] for the number of spots is significantly different by experimental and control assays, i.e., if the experimental line is statistically significantly different from the control line. To determine differences in ex vivo T cell frequencies between groups, Wilcoxon/Kruskal-Wallis analysis was used.
###end p 63
###begin title 64
Online supplemental material.
###end title 64
###begin p 65
###xml 0 7 0 7 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Ex vivo</named-content>
Ex vivo T cell frequencies and MHC binding assays were performed exactly as described above.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin title 67
###xml 2 4 2 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
IC50 (nM) of Peptide Binding to HLA
###end title 67
###begin p 68
(87 KB PDF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin title 70
Accession Numbers
###end title 70
###begin p 71
###xml 46 49 <span type="species:ncbi:1773">Mtb</span>
The accession numbers from TubercuList () for Mtb proteins discussed in the manuscript are as follows: 19kd (Rv3763); Ag85B (Rv1886c), CFP10 (Rv3874); ESAT 6 (Rv3875); EsxG (Rv0287), Mtb8.4 (Rv1174c); Mtb9.9A (Rv1793); Mtb39 (Rv1196).
###end p 71
###begin p 72
We are grateful to Roger Croteau for his expert assistance.
###end p 72
###begin title 73
Abbreviations
###end title 73
###begin p 74
antigen-presenting cell
###end p 74
###begin p 75
cytomegalovirus
###end p 75
###begin p 76
dendritic cell
###end p 76
###begin p 77
lymphoblastoid cell line
###end p 77
###begin p 78
latent tuberculosis infection
###end p 78
###begin p 79
major histocompatibility complex
###end p 79
###begin p 80
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis
###end p 80
###begin p 81
peripheral blood mononuclear cell
###end p 81
###begin p 82
tuberculosis
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Global tuberculosis control: Surveillance, planning, financing
###end article-title 84
###begin article-title 85
Immunology of tuberculosis
###end article-title 85
###begin article-title 86
Immunity to tuberculosis
###end article-title 86
###begin article-title 87
The role of cytotoxic T lymphocytes in infectious disease: History, criteria, and state of the art
###end article-title 87
###begin article-title 88
###xml 44 70 44 70 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 44 70 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
The dynamics of infection following BCG and Mycobacterium tuberculosis challenge in T-cell-deficient mice
###end article-title 88
###begin article-title 89
###xml 23 49 23 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 23 49 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells
###end article-title 89
###begin article-title 90
Protection against tuberculosis by passive transfer with T-cell clones recognizing mycobacterial heat-shock protein 65
###end article-title 90
###begin article-title 91
###xml 91 117 91 117 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 91 117 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
###end article-title 91
###begin article-title 92
###xml 19 38 19 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium bovis</named-content>
###xml 19 38 <span type="species:ncbi:1765">Mycobacterium bovis</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance
###end article-title 92
###begin article-title 93
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice
###end article-title 93
###begin article-title 94
###xml 67 93 67 93 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 67 93 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
###end article-title 94
###begin article-title 95
###xml 98 124 98 124 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 98 124 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis
###end article-title 95
###begin article-title 96
###xml 86 112 86 112 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 86 112 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice
###end article-title 96
###begin article-title 97
###xml 40 66 40 66 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 40 66 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
CD8+ T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- mice, but provide minimal protection
###end article-title 97
###begin article-title 98
###xml 50 76 50 76 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 50 76 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells
###end article-title 98
###begin article-title 99
###xml 61 87 61 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 61 87 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: Definition of antigenic specificity
###end article-title 99
###begin article-title 100
###xml 32 35 <span type="species:ncbi:1773">Mtb</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells
###end article-title 100
###begin article-title 101
###xml 79 105 79 105 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 79 105 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis
###end article-title 101
###begin article-title 102
###xml 16 43 16 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis:</italic>
###xml 16 42 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprotein
###end article-title 102
###begin article-title 103
Application of combinatorial library methods in cancer research and drug discovery
###end article-title 103
###begin article-title 104
###xml 66 84 66 84 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium bovi</named-content>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 66 89 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro
###end article-title 104
###begin article-title 105
###xml 53 79 53 79 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 53 79 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells
###end article-title 105
###begin article-title 106
###xml 119 124 <span type="species:ncbi:9606">human</span>
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family
###end article-title 106
###begin article-title 107
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool
###end article-title 107
###begin article-title 108
###xml 62 88 62 88 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 62 88 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection
###end article-title 108
###begin article-title 109
Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
###end article-title 109
###begin article-title 110
Antigen discovery and tuberculosis vaccine development in the post-genomic era
###end article-title 110
###begin article-title 111
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 48 51 <span type="species:ncbi:9606">man</span>
Tuberculosis vaccine development; from mouse to man
###end article-title 111
###begin article-title 112
###xml 36 62 36 62 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 36 62 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 135 150 <span type="species:ncbi:10090">transgenic mice</span>
###xml 155 161 <span type="species:ncbi:9606">humans</span>
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA- transgenic mice and humans
###end article-title 112
###begin article-title 113
###xml 69 95 69 95 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 69 95 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
HLA-B*35-Restricted CD8 T Cell Epitopes in the Antigen 85 Complex of Mycobacterium tuberculosis
###end article-title 113
###begin article-title 114
The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65
###end article-title 114
###begin article-title 115
###xml 45 71 45 71 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 45 71 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c
###end article-title 115
###begin article-title 116
###xml 30 56 30 56 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 30 56 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes
###end article-title 116
###begin article-title 117
###xml 71 97 71 97 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 71 97 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis-specific CD8+ T cells
###end article-title 117
###begin article-title 118
###xml 0 26 0 26 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: The relative contribution of classical versus nonclassical HLA restriction
###end article-title 118
###begin article-title 119
CD8 T cell responses to infectious pathogens
###end article-title 119
###begin article-title 120
T cells and viral persistence: Lessons from diverse infections
###end article-title 120
###begin article-title 121
###xml 71 74 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
###end article-title 121
###begin article-title 122
###xml 18 31 18 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
Identification of Mycobacterium DNA in an Egyptian Pott's disease of 5,400 years old
###end article-title 122
###begin article-title 123
###xml 18 44 18 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 18 44 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy
###end article-title 123
###begin article-title 124
A roadmap for the immunomics of category A-C pathogens
###end article-title 124
###begin article-title 125
A community resource benchmarking predictions of peptide binding to MHC-I molecules
###end article-title 125
###begin article-title 126
###xml 73 99 73 99 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 73 99 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection
###end article-title 126
###begin article-title 127
###xml 17 38 <span type="species:ncbi:10359">human cytomegalovirus</span>
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
###end article-title 127
###begin article-title 128
###xml 128 154 128 154 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 128 154 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis
###end article-title 128
###begin article-title 129
###xml 126 152 126 152 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 126 152 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide
###end article-title 129
###begin article-title 130
###xml 4 30 4 30 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 4 30 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2
###end article-title 130
###begin article-title 131
###xml 118 137 118 137 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium bovis</named-content>
###xml 87 93 <span type="species:ncbi:10090">murine</span>
###xml 118 141 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein
###end article-title 131
###begin article-title 132
###xml 2 28 2 28 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 2 28 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low- molecular-mass culture filtrate protein (CFP-10)
###end article-title 132
###begin article-title 133
###xml 48 74 48 74 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 122 141 122 141 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium bovis</named-content>
###xml 48 74 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 122 145 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG
###end article-title 133
###begin article-title 134
###xml 85 111 85 111 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 85 111 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis
###end article-title 134
###begin article-title 135
###xml 77 103 77 103 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 77 103 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family
###end article-title 135
###begin article-title 136
###xml 86 112 86 112 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 86 112 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis
###end article-title 136
###begin article-title 137
###xml 27 53 27 53 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria
###end article-title 137
###begin article-title 138
###xml 24 50 24 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 24 50 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Towards the proteome of Mycobacterium tuberculosis
###end article-title 138
###begin article-title 139
###xml 69 88 69 88 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium bovis</named-content>
###xml 69 88 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Cloning and characterization of the gene for the '19 kDa' antigen of Mycobacterium bovis
###end article-title 139
###begin article-title 140
###xml 83 109 83 109 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 83 109 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis
###end article-title 140
###begin article-title 141
###xml 44 49 <span type="species:ncbi:9606">human</span>
Proliferating dendritic cell progenitors in human blood
###end article-title 141
###begin article-title 142
###xml 0 26 0 26 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells
###end article-title 142
###begin article-title 143
Unit 18.3: Measurement of MHC/peptide interactions by gel filtration
###end article-title 143
###begin article-title 144
###xml 94 108 <span type="species:ncbi:9544">rhesus macaque</span>
High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque
###end article-title 144
###begin p 145
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions</bold>
Author contributions. DAL, AS, and DML conceived and designed the experiments. EW, GMS, KET, MSC, MDN, MEC, and JS performed the experiments. DAL, GMS, JS, and DML analyzed the data. AS contributed reagents/materials/analysis tools. DAL and DML wrote the paper.
###end p 145
###begin p 146
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by a VA Merit Review Grant and the Portland VA Medical Center, and by the ALA Career Investigator Awards (DML), US National Institutes of Health HHSN266200400081C (NO1-A1-400081) (DAL and DML), R01AI054474 (DAL), and R01AI48090 (DML).
###end p 146
###begin p 147
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 147

